R&D and
Innovation
nano-biotechnology
Dr. Ronit Shaltiel Karyo is a scientific leader with a Ph.D in Biotechnology and an MBA. Starting from her academic years, Dr. Ronit gained years of experience in researching CNS related indications, with the focus on Alzheimer’s and Parkinson’s diseases. Following her graduation, Dr. Ronit worked for many years as a director of R&D at Neuroderm, a pharma company which develop drug-device combination products for Parkinson’s patients. The company was acquired in 2017 for $1.1 billion by the Giant Japanese company, Mitsubishi Tanabe.
Dr. Ronit brings great experience in both the pharma industry and the cosmetic/OTC/wellness industry, with broad international experience in biotechnological, pharmaceutical, device, and cannabis companies.
